Vaping also increased significantly among this age group last year, despite leveling off during the first year of the Covid-19 pandemic.
People ages 19 to 30 were surveyed as part of the Monitoring the Future study, conducted by researchers at the University of Michigan and funded by the National Institutes of Health since 1975.
Vaping prevalence is growing even faster among young adults and on a steady upward trend, according to the study. After slowing in 2020, rates of nicotine vaping in 2021 were nearly triple what they were five years ago and rates of marijuana vaping were about double. Overall, young adults are less likely to use hallucinogens than marijuana. But after holding steady for decades, use of hallucinogens among young adults started to "increase dramatically" during the pandemic and reached a record-high in 2021. About 8% of young adults reported using substances such as LSD, PCP and psychedelic mushrooms in the past year, up from just 3% in 2011.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Post-COVID Symptoms in Kids: Not Always Long COVIDDo kids get long COVID? Look for these unique signs and symptoms. MedTwitter
Read more »
Released during COVID, some people are sent back to prison with little or no warning'Where is the fairness?' One mother was sent back after a single failed drug test, and her family's life has now been turned upside down for more than a year.
Read more »
24% of Alabama students cancel college plans because of COVID, report statesNearly 30 percent of students across the U.S. are opting out of attending college altogether.
Read more »
Pfizer seeks OK of updated COVID vaccine booster for fallPfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives.
Read more »
Dr. Anthony Fauci, nation's top infectious disease expert at center of COVID response, to step downDr. Anthony Fauci, the nation's top infectious disease expert at the center of the COVID-19 response, says he will step down in December to pursue the next chapter of his career.
Read more »